Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 56.34% vs 92.97% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is -833.33% vs -95.52% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 150.00% vs -57.41% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 92.00% vs -3.85% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Bandaram Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -10.44% vs -8.80% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 56.34% vs 92.97% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -215.79% vs 111.11% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -833.33% vs -95.52% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -25.32% vs 87.80% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 150.00% vs -57.41% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 14.29% vs -8.70% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 92.00% vs -3.85% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025